<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CTRT | Nano Publications</title>
	<atom:link href="https://bibliography.nanobiotix.com/fr/tag/ctrt-fr/feed/" rel="self" type="application/rss+xml" />
	<link>https://bibliography.nanobiotix.com/fr/</link>
	<description>Navigate through all Nanobiotix publications online</description>
	<lastBuildDate>Tue, 24 May 2022 15:51:31 +0000</lastBuildDate>
	<language>fr-FR</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.0</generator>

<image>
	<url>https://bibliography.nanobiotix.com/wp-content/uploads/2019/11/cropped-n-icon-512x512-32x32.png</url>
	<title>CTRT | Nano Publications</title>
	<link>https://bibliography.nanobiotix.com/fr/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>2018 – ESTRO – Hafnium Oxide Nanoparticles and Radiotherapy:  A Promising New Treatment Strategy</title>
		<link>https://bibliography.nanobiotix.com/fr/2018-estro-hafnium-oxide-nanoparticles-and-radiotherapy-a-promising-new-treatment-strategy/</link>
					<comments>https://bibliography.nanobiotix.com/fr/2018-estro-hafnium-oxide-nanoparticles-and-radiotherapy-a-promising-new-treatment-strategy/#respond</comments>
		
		<dc:creator><![CDATA[nano-pub]]></dc:creator>
		<pubDate>Thu, 21 Jun 2018 17:07:33 +0000</pubDate>
				<category><![CDATA[Abstracts]]></category>
		<category><![CDATA[Donnée clinique de NBTXR3]]></category>
		<category><![CDATA[Foie]]></category>
		<category><![CDATA[Rectum]]></category>
		<category><![CDATA[STM]]></category>
		<category><![CDATA[Tête & Cou]]></category>
		<category><![CDATA[CTRT]]></category>
		<category><![CDATA[EBRT]]></category>
		<category><![CDATA[Hafnium Oxide]]></category>
		<category><![CDATA[HNSCC]]></category>
		<category><![CDATA[IMRT]]></category>
		<category><![CDATA[Nanomedicine]]></category>
		<category><![CDATA[NBTXR3]]></category>
		<category><![CDATA[Radiotherapy]]></category>
		<category><![CDATA[SBRT]]></category>
		<guid isPermaLink="false">http://bibliography.nanobiotix.com/2018-estro-hafnium-oxide-nanoparticles-and-radiotherapy-a-promising-new-treatment-strategy/</guid>

					<description><![CDATA[<p>With recent advances in radiation delivery techniques, an increasing number of cancer patients undergo radiotherapy. However, due to the non-targeted nature of radiotherapy, doses are limited by potential toxicity to surrounding normal tissue. Thus, a major challenge remains to develop new strategies to improve the tumor selectivity of radiation therapy. […]</p>
The post <a href="https://bibliography.nanobiotix.com/fr/2018-estro-hafnium-oxide-nanoparticles-and-radiotherapy-a-promising-new-treatment-strategy/">2018 – ESTRO – Hafnium Oxide Nanoparticles and Radiotherapy:  A Promising New Treatment Strategy</a> first appeared on <a href="https://bibliography.nanobiotix.com/fr/">Nano Publications</a>.]]></description>
										<content:encoded><![CDATA[<div class="az-main-section-content az-module az-padding-top-0 az-padding-bottom-0 az-section-default az-section-with-equal no-animate-content az-module-bg-color">
        <div class="az-module-wrap-bg">
            <div class="az-module-wrapper-bg" style="background: #28282e;"></div>
            
        </div><div class="container-fluid az-container-no-padding"><div class="row row-parent az-gutter-0 az-equal"><div class="single-clms col-md-12 az-main-col-content az-module az-v-space-clm no-animate-content az-module-default"><div class="az-col az-clm-padding-0" ><div class="az-col-cont"><div class="row row-inner az-padding-top-0 az-padding-bottom-0 az-gutter-0 az-equal no-animate-content"><div data-animation-type="ani-in" data-animation-in="fadeInUp" data-animation-out="none" data-animation-speed="default" data-animation-delay="200" data-offset-down="90" data-offset-up="none" class="single-clms col-md-6 az-main-col-content az-module az-col-pos-middle az-v-space-clm animate-content az-module-bg-image"><div class="az-col az-clm-padding-105" data-col-min-height-default="700" data-col-min-height-sm="400" data-col-min-height-xs="350" style="min-height: 700px;">
        <div class="az-module-wrap-bg">
            <div class="az-module-wrapper-bg  az-imagesLoadedBg" style="background-image: url(https://bibliography.nanobiotix.com/wp-content/uploads/2017/02/Author.jpg); background-position: center center; background-repeat: no-repeat; background-size: cover;">
            
    <div class="az-module-mask-group">
        <span class="az-module-mask-bg is-bg main-mask"></span>
        
    </div>
            </div>
            
        </div><div class="az-col-cont"><div class="az-content-element-wrapper az-empty-divider hidden-lg hidden-md" style="height: 60px;"></div>
<div class="az-content-element-wrapper az-box-icon-wrapper az-margin-top-0 az-margin-bottom-0 no-animate-content">
    <div class="az-box-icon az-box-icon-top">
            <div class="az-icon-container" style="color: #ffffff; font-size: 50px;"><i class="fa fa-edit"></i>
            </div><div class="az-box-icon-content az-font-custom az-font-color-custom" style="color: #ffffff;"><h3 class="az-box-icon-title">Authors</h3><p>Le Tourneau C.<span class="notes up">1</span>, Le Pechoux C.<span class="notes up">2</span>, Kantor G.<span class="notes up">3</span>, Carrere S.<span class="notes up">4</span>, Bonvalot S.<span class="notes up">1</span>, Le Prise E.<span class="notes up">5</span>, Nguyen F.<span class="notes up">2</span>, Baumann A. S.<span class="notes up">6</span>, Vendrely V.<span class="notes up">7</span>, Bronowicki J. P.<span class="notes up">8</span>, Moreno-Garcia V.<span class="notes up">9</span>, Delannes M.<span class="notes up">10</span>, Thariat J.<span class="notes up">11</span>, Papai Z.<span class="notes up">12</span>, Ruthowski P.<span class="notes up">13</span>, Tiangco B.<span class="notes up">14</span>, Rastrelli M.<span class="notes up">15</span>, Agoston P.<span class="notes up">16</span>, Sunyach M.P.<span class="notes up">17</span>, Rubi Li K.<span class="notes up">18</span>, Mervoyer A.<span class="notes up">19</span>, Sy-Ortin T.<span class="notes up">20</span>, Hong A.<span class="notes up">21</span>, Anghel R.<span class="notes up">22</span>, Gronchi A.<span class="notes up">23</span><span class="notes"><br />
1 – Institut Curie, Oncology, Paris, France<br />
2 – Institut Gustave Roussy, Oncology, Villejuif, France<br />
3 – Institut Bergonié, Oncology, Bordeaux, France<br />
4 – ICM, Oncology, Montpellier, France<br />
5 – Eugène Marquis, Oncology, Rennes, France<br />
6 – Cancérologie de Lorraine, Oncology, Nancy, France<br />
7 – Hôpital du Haut-Lévêque, Oncology, Bordeaux, France<br />
8 – Hôpitaux de Brabois CHU Nancy, Oncology, Nancy, France<br />
9 – START Madrid, Oncology, Madrid, Spain<br />
10 – Claudius Regaud, Oncology, Toulouse, France<br />
11 – Antoine Lacassagne, Oncology, Nice, France<br />
12 – Medical Centre- Hungarian Defence Forces, Oncology, Budapest, Hungary<br />
13 – Maria Sklodowska-Curie Institute &#8211; Oncology Center, Warsaw, Poland<br />
14 – The Medical City, Oncology, Pasig City, Philippines<br />
15 – Veneto institute of oncology, Padua Italy<br />
16 – Országos Onkológiai Intézet, Oncology, Budapest, Hungary<br />
17 – Centre Léon Bérard, Oncology, Lyon, France<br />
18 – St. Luke’s Medical Center, Oncology, Quezon City, Philippines<br />
19 – Centre Rene Gauducheau- CLCC Nantes Atlantique, Oncology, St Herblain, France<br />
20 – University of Santo Thomas, Oncology, Manila, Philippines<br />
21 – Chris O’Brien Lifehouse, Oncology, Sidney, Australia<br />
22 – Institutul Oncologic Bucuresti- “Prof. Dr. Alexandru Trestioreanu”, Oncology, Bucharest, Romania<br />
23 – Fondazione IRCCS Istituto Nazionale dei Tumori, Oncology, Milan, Italy</span></p>
</div></div>
</div>
<div class="az-content-element-wrapper az-empty-divider hidden-lg hidden-md" style="height: 60px;"></div></div></div></div><div data-animation-type="ani-in" data-animation-in="fadeInUp" data-animation-out="none" data-animation-speed="default" data-animation-delay="300" data-offset-down="90" data-offset-up="none" class="single-clms col-md-6 az-main-col-content az-module az-col-pos-middle az-v-space-clm animate-content az-module-bg-color"><div class="az-col az-clm-padding-105" >
        <div class="az-module-wrap-bg">
            <div class="az-module-wrapper-bg" style="background: #ffffff;"></div>
            
        </div><div class="az-col-cont"><div class="az-content-element-wrapper az-empty-divider hidden-lg hidden-md" style="height: 60px;"></div>
<div class="az-content-element-wrapper az-box-icon-wrapper az-margin-top-0 az-margin-bottom-0 no-animate-content">
    <div class="az-box-icon az-box-icon-top">
            <div class="az-icon-container" style="color: #28282e; font-size: 50px;"><i class="az-icon az-icon-layers2"></i>
            </div><div class="az-box-icon-content"><h3 class="az-box-icon-title">Summary</h3><p>With recent advances in radiation delivery techniques, an increasing number of cancer patients undergo radiotherapy. However, due to the non-targeted nature of radiotherapy, doses are limited by potential toxicity to surrounding normal tissue. Thus, a major challenge remains to develop new strategies to improve the tumor selectivity of radiation therapy. Nanobiotix has developed NBTXR3 &#8211; a hafnium oxide nanoparticle that can enter tumor cells and deposit high levels of energy in cells when exposed to ionizing radiation thereby increasing tumor-specific physical killing through DNA damage/cell destruction and enhancing the intratumoral immune profile.</p>
<p>At <em>2018 ESTRO</em>, an overview of NBTXR3 was presented, describing its role in current 7 clinical trials.</p>
</div></div>
</div>
<div class="az-content-element-wrapper az-empty-divider hidden-lg hidden-md" style="height: 60px;"></div></div></div></div></div></div></div></div></div></div></div>The post <a href="https://bibliography.nanobiotix.com/fr/2018-estro-hafnium-oxide-nanoparticles-and-radiotherapy-a-promising-new-treatment-strategy/">2018 – ESTRO – Hafnium Oxide Nanoparticles and Radiotherapy:  A Promising New Treatment Strategy</a> first appeared on <a href="https://bibliography.nanobiotix.com/fr/">Nano Publications</a>.]]></content:encoded>
					
					<wfw:commentRss>https://bibliography.nanobiotix.com/fr/2018-estro-hafnium-oxide-nanoparticles-and-radiotherapy-a-promising-new-treatment-strategy/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
